
Legal group urges CMS to cover BiDil for black Medicare patients
Group contends CMS is promoting a less expensive generic substitute.
The Centers for Medicare and Medicaid Services' decision not to provide insurance coverage for Bidil (isosorbide dinitrate/hydralazine, Nitromed) when it is the only drug approved to treat African Americans with heart failure is racially insensitive. So contends the
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































